Regeneron Pharmaceuticals, Inc.
COMPOSITIONS AND METHODS FOR TREATING JUVENILE IDIOPATHIC ARTHRITIS
Last updated:
Abstract:
The present disclosure provides compositions and methods of treating and improving the symptoms of systemic juvenile idiopathic arthritis and polyarticular-course juvenile idiopathic arthritis using an antibody that specifically binds human interleukin-6 receptor (hIL-6R).
Status:
Application
Type:
Utility
Filling date:
31 Jan 2020
Issue date:
29 Oct 2020